GARDEN CITY, NY, Oct. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and diagnostics company, today announced that it will be ...
GARDEN CITY, NY, Oct. 17, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and diagnostics company, today announced ...
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare ...
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight.
GARDEN CITY, NY - ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and diagnostics company, announced today its financial outlook for 2025, projecting substantial revenue and pre-tax ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
DALLAS, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Westwood Holdings Group, Inc. (NYSE:WHG) will release its third quarter 2024 earnings after the close of the New York Stock Exchange on Wednesday, October 30, ...